A new operating model for pharma that combines deep scientific expertise, global operations and AI-native technology with contractual accountability for outcomes.
Most transformation models separate the technology provider from the team responsible for delivering the operation.
We bring both.
We establish the capability around your operating model, products, processes and regulatory environment.
Experienced pharma teams run the operation with defined governance, SLAs, KPIs and executive oversight.
We redesign the operation around technology and AI rather than simply moving the existing process to a lower-cost environment.
Once mature, the capability can be transferred back to the customer as a functioning, optimized operation.
A capability built for you, transformed with you and ultimately owned by you.
We do not sell a transformation business case and leave the customer to realize it.
Synapmed assumes operational accountability while TheragenX provides the technology and transformation layer. That allows us to put contractual accountability behind the efficiency we promise.

TheragenX is an AI-native platform for regulated pharmaceutical operations, connecting scientific workflows, operational execution and real-time intelligence through one architecture.
Human expertise remains in control. AI accelerates execution, intelligence and decision support.
Quality, security, traceability and inspection readiness are designed into the operating model and technology architecture.
Synapmed brings the physicians, pharmacists, scientists, operations leaders, quality professionals and regulatory expertise behind the technology.

Nearly two decades of leadership across pharma, life sciences, technology and global operations, including experience with Johnson & Johnson and Merck. Gargi leads the combined vision of scientific operations and AI-native transformation across Synapmed and TheragenX.

Leads customer strategy, strategic growth and operating transformation across safety, clinical, regulatory, medical affairs and real-world evidence, with a focus on connecting scientific operations with technology and measurable business outcomes.

Leads sales and marketing, working with pharma leaders to shape engagements around the Build, Operate, Transform, Transfer model.

Physician and senior safety leader with experience including Johnson & Johnson. His expertise spans clinical development, post-marketing pharmacovigilance, PV operations, medical review, signal science, benefit-risk evaluation and global safety strategy.

Swati brings a strong understanding of patient safety processes and technology, working at the intersection of science and innovation. At TheragenX, she bridges the gap between scientists and technologists, translating complex pharmacovigilance requirements into intuitive, practical technology solutions that improve how patient safety is managed.